Antiangiogenesis Therapy of Endometriosis Using PAMAM as a Gene Vector in a Noninvasive Animal Model

Table 5

Lesion weight of different groups (gram, mean ± SD).

Group	Lesion weight
(1) HD PAMAM-Es^a	0.0104±0.0077
(2) LD PAMAM-Es^b	0.0140±0.0097
(3) Lipofectamine-Es	0.0253±0.0158
(4) PAMAM^a	0.0350±0.0245
(5) PBS^a,b	0.0378±0.0170

aStatistic significant difference between Group 1 and Group 4 and Group 1 and Group 5 by Bonferroni test. ^bStatistic significant difference between Group 2 and Group 5.